BDNF’s preferential receptor, tropomyosin kinase B receptor (TrkB), is widely distributed in the central nervous system, including dopaminergic neurons of the substantia nigra, and increasing BDNF and/or TrkB expression is considered beneficial in PD [54,55]. Here, BDNF is linked to Parkinson disease.